Erythropoietin Market Gains Momentum Amid Rising Incidence Of Chronic Kidney Diseases Is Supporting Development Across The Erythropoietin (EPO) Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Much Larger Will The Erythropoietin (EPO) Market Become By 2030 Compared To 2026?

The erythropoietin (epo) market size has experienced significant growth in recent years. It is projected to increase from $19.25 billion in 2025 to $21.46 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.5%. Factors contributing to its historical growth include the escalating prevalence of anemia, the rising incidence of chronic kidney disease, the proven clinical efficacy of epo therapy, innovations in recombinant biologic manufacturing, and the expanded application of epo in addressing cancer-related anemia.

The erythropoietin (epo) market is projected for significant expansion over the coming years, with its valuation set to reach $35.04 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.0%. This anticipated growth during the forecast period is propelled by factors such as a rise in biosimilar approvals, an expanding elderly demographic, an increase in the worldwide volume of dialysis patients, advancements in sustained-release epo medications, and better availability of biologic treatments in developing economies. Key trends identified for the forecast timeframe involve the broader application of erythropoietin in chronic kidney disease, a surge in the embrace of biosimilar erythropoietin treatments, an escalating demand for epo formulations with prolonged action, increased deployment of epo in supportive oncology care, and enhanced regulatory scrutiny concerning epo’s safety and appropriate dosage.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3436&type=smp

Which Major Factors Are Contributing To The Development Of The Erythropoietin (EPO) Market?

The growing prevalence of chronic kidney diseases is expected to boost the demand within the erythropoietin market in the foreseeable future. The increasing number of individuals afflicted with chronic kidney disease necessitates the use of erythropoietin, which is vital for red blood cell production and enhancing immunity. For example, as reported in 2023 by the Centers for Disease Control, a federal agency in the US, roughly 14% of U.S. adults, amounting to approximately 35.5 million individuals, were estimated to suffer from chronic kidney disease (CKD). Consequently, this escalating occurrence of chronic kidney diseases is increasing the need for erythropoietin, thereby propelling the market’s revenue growth.

What Key Segment Areas Are Included In The Erythropoietin (EPO) Market Assessment?

The erythropoietin (epo) market covered in this report is segmented –

1) By Product: Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Other Products

2) By Drug Class: Biologist, Biosimilar

3) By Application: Cancer, Hematology, Renal Diseases, Neurology, Other Applications

Subsegments:

1) By Epoetin-Alfa: Epoetin-Alfa, Epoetin-Alfa Biosimilars

2) By Epoetin-Beta: Epoetin-Beta, Epoetin-Beta Biosimilars

3) By Darbepoetin-Alfa: Darbepoetin-Alfa, Darbepoetin-Alfa Biosimilars

4) By Other Products: Peginesatide, Novel EPO Products

Which Trends Are Influencing The Direction Of The Erythropoietin (EPO) Market?

Major companies in the erythropoietin market are focusing on the introduction of oral medications that offer more convenient alternatives to traditional injectable therapies. This aims to improve patient comfort, compliance, and treatment flexibility, particularly for individuals managing chronic conditions like anemia in chronic kidney disease (CKD). For instance, in February 2023, GlaxoSmithKline (GSK), a UK-based multinational pharmaceutical and biotechnology company, launched Jesduvroq (daprodustat) tablets. This oral medication helps boost erythropoietin levels, assisting in the management of anemia in CKD patients by keeping hemoglobin levels within a target range. The key aim of Jesduvroq is to provide a more convenient alternative to injectable therapies, enhancing patient comfort, compliance, and treatment flexibility for dialysis patients.

Who Are The Major Companies Operating In The Erythropoietin (EPO) Market?

Major companies operating in the erythropoietin (epo) market are Amgen Inc., Roche Holding AG, Pfizer Inc., Merck & Co., Teva Pharmaceutical Industries Ltd., 3SBio Inc., Celltrion Inc., Intas Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Reliance Life Sciences Pvt. Ltd., Biocon Limited, Chugai Pharmaceutical Co., Kyowa Kirin Co. Ltd., Apotex Inc., CJ Healthcare Corp., STADA Arzneimittel AG, Hospira Inc., Sandoz International GmbH, Torrent Pharmaceuticals Ltd., LG Life Sciences Ltd., Sanofi S.A., Bayer AG, Hikma Pharmaceuticals.

Access The Complete Erythropoietin (EPO) Market Report:

https://www.thebusinessresearchcompany.com/report/erythropoietins-global-market-report

Which Region Leads The Erythropoietin (EPO) Market By Size?

North America was the largest region in the erythropoietin (EPO) market in 2025. The Middle East is expected to be the fastest growing region in the global erythropoietin (EPO) market analysis in the forecast period. The regions covered in the erythropoietin (epo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Erythropoietin (EPO) Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=3436&type=smp

Browse Through More Reports Similar to the Global Erythropoietin (EPO) Market 2026, By The Business Research Company

Protein Expression Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-expression-global-market-report

Therapeutic Proteins Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-proteins-global-market-report

Hematology Analyzers And Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795